Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.22.1
Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 27,204,269 $ 28,660,375
Acquired patents, net 12,615 16,227
Total assets 27,216,884 28,676,602
Current liabilities    
Accounts payable & accrued interest 220,845 710,971
Unreimbursed expenses 164,327 59,367
Advance from related party/shareholder 275,154
Total current liabilities 385,172 1,045,492
Total liabilities 385,172 1,045,492
Stockholders’ equity (deficit)    
Common stock, $0.001 par value; 100,000,000 shares authorized; 13,147,829 and 12,703,541 shares issued and outstanding as of December 31, 2021 and 2020, respectively 13,148 12,704
Additional paid-in capital 60,466,093 56,695,359
Accumulated deficit (33,647,529) (29,076,953)
Total stockholders’ equity 26,831,712 27,631,110
Total liabilities and stockholders’ equity $ 27,216,884 $ 28,676,602